1
|
Nie Y, Luo D, Yang M, Wang Y, Xiong L, Gao L, Liu Y, Liu H. A Meta-Analysis on the Relationship of the PON Genes and Alzheimer Disease. J Geriatr Psychiatry Neurol 2017; 30:303-310. [PMID: 28954597 DOI: 10.1177/0891988717731825] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
AIM This study aimed to evaluate the association of the paraoxonase (PON) gene variants and Alzheimer disease (AD) using meta-analysis. METHODS Relevant studies were identified by searching English and Chinese databases extensively. Allele and genotype frequencies for each included study were extracted. Newcastle-Ottawa Scale (NOS) was employed to assess the quality of included studies. The odds ratio (OR) with 95% confidence interval (95% CI) was calculated using a random-effects or fixed-effects model. A Q statistic was used to evaluate homogeneity, and Egger test and funnel plot were used to assess publication bias. RESULTS A total of 15 studies (involving 5 polymorphisms) were included and identified for the current meta-analysis. The NOS scores ranged from 7 to 8, meaning good quality of studies. It was found that the SS genotype of PON2 S311C polymorphism had an significant association with AD in the studied population (OR = 0.82, 95% CI: 0.68-0.99, P = .04), and the A allele of PON1 rs705379 polymorphism was positively related to AD in Caucasian population (OR = 1.21, 95% CI: 1.05-1.39, P = .009) as well as the GG genotype decreased AD risk significantly in Caucasians (OR = 0.7, 95% CI: 0.56-0.88, P = .002). However, there was no significant relationship between other 3 genetic variants of PON genes (L55 M, Q192 R, and -161C/T of PON1 gene) and AD. CONCLUSION Existing evidence indicates that the S311C polymorphism (SS genotype) and the rs705379 (the A allele and GG genotype) are associated with risk of AD in studied population. Future studies with larger sample sizes will be necessary to confirm the present results.
Collapse
Affiliation(s)
- Yi Nie
- 1 Clinical Medical College, Southwest Medical University, Luzhou, People's Republic of China
| | - Danyang Luo
- 1 Clinical Medical College, Southwest Medical University, Luzhou, People's Republic of China
| | - Min Yang
- 2 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center (KUMC), Kansas City, KS, USA
| | - Yi Wang
- 3 Department of Neurology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China
| | - Li Xiong
- 4 Department of Rehabilitation, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, People's Republic of China
| | - Li Gao
- 5 Department of Neurology, The Third People's Hospital of Chengdu, Southwest Medical University, Chengdu, People's Republic of China
| | - Yan Liu
- 5 Department of Neurology, The Third People's Hospital of Chengdu, Southwest Medical University, Chengdu, People's Republic of China
| | - Hua Liu
- 1 Clinical Medical College, Southwest Medical University, Luzhou, People's Republic of China.,5 Department of Neurology, The Third People's Hospital of Chengdu, Southwest Medical University, Chengdu, People's Republic of China
| |
Collapse
|
2
|
Protectors or Traitors: The Roles of PON2 and PON3 in Atherosclerosis and Cancer. J Lipids 2012; 2012:342806. [PMID: 22666600 PMCID: PMC3361228 DOI: 10.1155/2012/342806] [Citation(s) in RCA: 61] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2011] [Accepted: 02/05/2012] [Indexed: 02/06/2023] Open
Abstract
Cancer and atherosclerosis are major causes of death in western societies. Deregulated cell death is common to both diseases, with significant contribution of inflammatory processes and oxidative stress. These two form a vicious cycle and regulate cell death pathways in either direction. This raises interest in antioxidative systems. The human enzymes paraoxonase-2 (PON2) and PON3 are intracellular enzymes with established antioxidative effects and protective functions against atherosclerosis. Underlying molecular mechanisms, however, remained elusive until recently. Novel findings revealed that both enzymes locate to mitochondrial membranes where they interact with coenzyme Q10 and diminish oxidative stress. As a result, ROS-triggered mitochondrial apoptosis and cell death are reduced. From a cardiovascular standpoint, this is beneficial given that enhanced loss of vascular cells and macrophage death forms the basis for atherosclerotic plaque development. However, the same function has now been shown to raise chemotherapeutic resistance in several cancer cells. Intriguingly, PON2 as well as PON3 are frequently found upregulated in tumor samples. Here we review studies reporting PON2/PON3 deregulations in cancer, summarize most recent findings on their anti-oxidative and antiapoptotic mechanisms, and discuss how this could be used in putative future therapies to target atherosclerosis and cancer.
Collapse
|
3
|
Hegele RA. Genetic prediction of coronary heart disease: Lessons from Canada. Scandinavian Journal of Clinical and Laboratory Investigation 2010. [DOI: 10.1080/00365519909168339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
4
|
Li WF, Sun CW, Cheng TJ, Chang KH, Chen CJ, Wang SL. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan. Toxicol Appl Pharmacol 2009; 236:246-53. [PMID: 19371607 DOI: 10.1016/j.taap.2009.01.019] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2008] [Revised: 01/23/2009] [Accepted: 01/30/2009] [Indexed: 12/22/2022]
Abstract
To understand whether human paraoxonase 1 (PON1) would modulate the risk for arsenic-related atherosclerosis, we studied 196 residents from an arseniasis-endemic area in Southwestern Taiwan and 291 age- and sex-matched residents from a nearby control area where arsenic exposure was found low. Carotid atherosclerosis was defined by a carotid artery intima-media wall thickness (IMT) of >1.0 mm. Prevalence of carotid atherosclerosis was increased in the arseniasis-endemic area as compared to the control area after adjustment for conventional risk factors (OR=2.20, p<0.01). The prevalence was positively associated with cumulative arsenic exposure (mg/L-year) in a dose-dependent manner. Multiple logistic regression analysis showed that in the endemic group, low serum PON1 activity was an independent risk factor for atherosclerosis (OR=4.18 low vs. high, p<0.05). For those of low PON1 activity and high cumulative arsenic exposure, the odds ratio for the prevalence of atherosclerosis was further increased up to 5.68 (p<0.05). No significant association was found between atherosclerosis and four polymorphisms of the PON gene cluster (PON1 -108C/T, PON1 Q192R, PON2 A148G, PON2 C311S). However, genetic frequencies of certain alleles including PON1 Q192, PON2 G148 and PON2 C311 were found increased in the endemic group as compared to the controls and a general Chinese population, indicating a possible survival selection in the endemic group after a long arsenic exposure history. Our results showed a significant joint effect between arsenic exposure and serum PON1 activity on carotid atherosclerosis, suggesting that subjects of low PON1 activity may be more susceptible to arsenic-related cardiovascular disease.
Collapse
Affiliation(s)
- Wan-Fen Li
- Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Zhunan, Taiwan
| | | | | | | | | | | |
Collapse
|
5
|
Shin BS, Oh SY, Kim YS, Kim KW. The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol Scand 2008; 117:237-43. [PMID: 17854416 DOI: 10.1111/j.1600-0404.2007.00929.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVES The paraoxonase (PON) gene can reduce the risk of developing atherosclerosis. We investigated the associations between PON polymorphisms and ischemic stroke. We also investigated the associations between PON polymorphisms and lipid profile in stroke patients. METHODS A total of 350 patients with ischemic stroke and 242 control subjects in Korean population were genotyped for the PON1M55 L, PON1Q192R, PON2A148 G and PON2S311C polymorphisms using melting point analysis with LightCycler real-time polymerase chain reaction (PCR) technology. RESULTS There were no significant differences in genotype and allele distribution of the PON polymorphisms between the ischemic stroke patients and control subjects. The concentration of total homocysteine was significantly different in the PON1M55 L polymorphism (P = 0.047), and the apolipoprotein (Apo)B concentration was significantly different in the PON1Q192R polymorphism (P = 0.02) in stroke patients. The concentrations of low-density lipoprotein (LDL) cholesterol and ApoB were significantly different between the PON2A148 G (P = 0.011, P = 0.000, respectively) and PON2S311C polymorphisms (P = 0.046, P = 0.003, respectively) in stroke patients. CONCLUSIONS This study did not provide association between PON gene polymorphisms and ischemic stroke. However, it confirmed that the PON1L55 L allele is associated with plasma concentration of total homocysteine and that the PON2G148 G and PON2S311S allele is associated with plasma concentrations of LDL cholesterol and ApoB.
Collapse
Affiliation(s)
- B-S Shin
- Department of Neurology, Chonbuk National University Hospital and Medical School, Keumamdong, Jeonju, Chonbuk, Republic of Korea
| | | | | | | |
Collapse
|
6
|
Levy E, Trudel K, Bendayan M, Seidman E, Delvin E, Elchebly M, Lavoie JC, Precourt LP, Amre D, Sinnett D. Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats. Am J Physiol Gastrointest Liver Physiol 2007; 293:G1252-61. [PMID: 17916643 DOI: 10.1152/ajpgi.00369.2007] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Oxidative stress is a cardinal manifestation of various intestinal disorders. However, very little knowledge is available on the intestine's inherent defense mechanisms against free radicals. This study was designed to determine the protein expression, subcellular localization and oxidative stress response of paraoxonase 2 (PON2), a member of a powerful antioxidant family in human and rat intestine. Biochemical and ultrastructural experiments all showed a substantial expression of PON2 in human and rat intestine. Western blot analysis disclosed higher levels of PON2 in the jejunum than in the duodenum, ileum, and colon. Cell fractionation revealed a predominant PON2 association with microsomes and lysosomes in the human jejunum, which differed from that in rats. PON2 was detected in the intestine as early as week 15 of gestation and was significantly increased by week 20. Iron ascorbate-mediated lipid peroxidation induced a marked decrease in PON2 expression in intestinal specimens coincidental to an abundant rise in malondialdehyde (MDA). On the other hand, preincubation with potent antioxidants, such as butylated hydroxytoluene, Trolox, and N-acetylcysteine, prevented iron-ascorbate-generating PON2 reduction in parallel with MDA suppression. Finally, the preincubation of permeabilized Caco-2 cells with purified PON2 led to a protection against iron-ascorbate-induced lipid peroxidation. These observations demonstrate that the human intestine is preferentially endowed with a marked PON2 expression compared with the rat intestine and this expression shows a developmental and intracellular pattern of distribution. Furthermore, our observations suggest PON2 protective effects against prooxidant stimuli in the small intestine.
Collapse
Affiliation(s)
- Emile Levy
- Department of Nutrition, Université de Montréal, Research Centre, CHU Sainte Justine, Montréal, Québec, Canada.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Shi J, Zhang S, Tang M, Liu X, Li T, Han H, Wang Y, Guo Y, Zhao J, Li H, Ma C. Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese. ACTA ACUST UNITED AC 2004; 120:201-4. [PMID: 14741412 DOI: 10.1016/j.molbrainres.2003.10.018] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The common polymorphism at codon 311 (C311S) of paraoxonase 2 gene (PON2) was investigated in 165 patients with sporadic late-onset Alzheimer's disease (LOAD) and 174 controls in Chinese. The PON2*C allele frequency was significantly increased in the patients as compared with controls. However, no significant difference was observed after stratification of apolipoprotein E (ApoE) epsilon4 allele. These results suggested that the PON2 polymorphism might be a risk factor for LOAD independent of ApoE epsilon4 status in Chinese.
Collapse
Affiliation(s)
- Jiajun Shi
- Key Laboratory of Biotherapy of Human Diseases, Department of Medical Genetics, West China Hospital and Division of Human Morbid Genomics, Ministry of Education, Sichuan University, Chengdu, 610041, China.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Rodrigo L, Gil F, Hernandez AF, Lopez O, Pla A. Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties. Biochem J 2003; 376:261-8. [PMID: 12946270 PMCID: PMC1223763 DOI: 10.1042/bj20030732] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2003] [Revised: 08/21/2003] [Accepted: 08/28/2003] [Indexed: 11/17/2022]
Abstract
Three paraoxonase genes (PON1, PON2 and PON3) have been described so far in mammals. Although considerable information is available regarding PON1, little is known about PON2 and PON3. PON3 has been isolated recently from rabbit serum [Draganov, Stetson, Watson, Billecke and La Du (2000) J. Biol. Chem. 275, 33435-33442] and liver [Ozols (1999) Biochem. J. 338, 265-275]. In the present study, we have identified the presence of PON3 in rat liver microsomes and a method for the purification to homogeneity is presented. PON3 has been purified 177-fold to apparent homogeneity with a final specific activity of 461 units/mg using a method consisting of seven steps: solubilization of the microsomal fraction, hydroxyapatite adsorption, chromatography on DEAE-Sepharose CL-6B, non-specific affinity chromatography on Cibacron Blue 3GA, two DEAE-cellulose steps and a final affinity chromatography on concanavalin A-Sepharose. SDS/PAGE of the final preparation indicated a single protein-staining band with an apparent molecular mass of 43 kDa. The isolated protein was identified by nanoelectrospray MS. Internal amino acid sequences of several peptides were determined and compared with those of human, rabbit and mouse PON3, showing a high similarity. Some biochemical properties of PON3 were also studied, including optimum pH, K(m) and heat and pH stability.
Collapse
Affiliation(s)
- Lourdes Rodrigo
- Departamento de Medicina Legal y Toxicología, Facultad de Medicina, Avda, Madrid 11, Granada 18071, Spain
| | | | | | | | | |
Collapse
|
9
|
Hegele RA, Zinman B, Hanley AJG, Harris SB, Barrett PH, Cao H. Genes, environment and Oji-Cree type 2 diabetes. Clin Biochem 2003; 36:163-70. [PMID: 12726923 DOI: 10.1016/s0009-9120(03)00004-3] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
The prevalence of type 2 diabetes in Canadian Oji-Cree is among the highest in the world. Our research has uncovered genetic determinants of Oji-Cree type 2 diabetes and related metabolic traits. The most important genetic discovery by far was the private G319S mutation in transcription factor HNF-1alpha, encoded by the HNF1A gene. HNF1A G319S was discovered by candidate gene sequencing and would have been missed using the currently favored strategy of genome-wide scanning. G319S was associated with increased odds of having type 2 diabetes across the whole study sample and in all subgroups, including adolescent Oji-Cree. Furthermore, G319S had specificity and positive predictive value of 97% and 95%, respectively, for developing type 2 diabetes by age 50. The protein bearing the G319S mutation had impaired function in vitro. Sigmoidal modeling showed that each dose of the G319S allele accelerated the median age of diabetes onset by about 7 yr. This approach also showed that environment more strongly accelerated the median age-of-onset of Oji-Cree diabetes onset than did G319S, which could have implications for intervention strategies to reduce the burden of this epidemic. There is also evidence for genetic determination of related metabolic traits in the Oji-Cree.
Collapse
|
10
|
Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, Reddy ST. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 2001; 276:44444-9. [PMID: 11579088 DOI: 10.1074/jbc.m105660200] [Citation(s) in RCA: 339] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The oxidation of apolipoprotein B-containing lipoproteins and cell membrane lipids is believed to play an integral role in the development of fatty streak lesions, an initial step in atherogenesis. We have previously shown that two antioxidant-like enzymes, paraoxonase (PON)-1 and PON3, are high density lipoprotein-associated proteins capable of preventing the oxidative modification of low density lipoprotein (LDL) (Reddy, S. T., Wadleigh, D. J., Grijalva, V., Ng, C., Hama, S., Gangopadhyay, A., Shih, D. M., Lusis, A. J., Navab, M., and Fogelman, A. M. (2001) Arterioscler. Thromb. Vasc. Biol. 21, 542-547). In the present study, we demonstrate that PON2 (i) is not associated with high density lipoprotein; (ii) has antioxidant properties; and (iii) prevents LDL lipid peroxidation, reverses the oxidation of mildly oxidized LDL (MM-LDL), and inhibits the ability of MM-LDL to induce monocyte chemotaxis. The PON2 protein was overexpressed in HeLa cells using the tetracycline-inducible ("Tet-On") system, and its antioxidant capacity was measured in a fluorometric assay. Cells that overexpressed PON2 showed significantly less intracellular oxidative stress following treatment with hydrogen peroxide or oxidized phospholipid. Moreover, cells that overexpressed PON2 were also less effective in oxidizing and modifying LDL and, in fact, were able to reverse the effects of preformed MM-LDL. Our results suggest that PON2 possesses antioxidant properties similar to those of PON1 and PON3. However, in contrast to PON1 and PON3, PON2 may exert its antioxidant functions at the cellular level, joining the host of intracellular antioxidant enzymes that protect cells from oxidative stress.
Collapse
Affiliation(s)
- C J Ng
- Atherosclerosis Research Unit, University of California, Los Angeles, California 90095-1679, USA
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Bétard C, Rasquin-Weber A, Brewer C, Drouin E, Clark S, Verner A, Darmond-Zwaig C, Fortin J, Mercier J, Chagnon P, Fujiwara TM, Morgan K, Richter A, Hudson TJ, Mitchell GA. Localization of a recessive gene for North American Indian childhood cirrhosis to chromosome region 16q22-and identification of a shared haplotype. Am J Hum Genet 2000; 67:222-8. [PMID: 10820129 PMCID: PMC1287080 DOI: 10.1086/302993] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/1999] [Accepted: 04/12/2000] [Indexed: 12/14/2022] Open
Abstract
North American Indian childhood cirrhosis (NAIC, or CIRH1A) is an isolated nonsyndromic form of familial cholestasis reported in Ojibway-Cree children and young adults in northwestern Quebec. The pattern of transmission is consistent with an autosomal recessive mode of inheritance. To map the NAIC locus, we performed a genomewide scan on three DNA pools of samples from 13 patients, 16 unaffected siblings, and 22 parents from five families. Analysis of 333 highly polymorphic markers revealed 3 markers with apparent excess allele sharing among affected individuals. Additional mapping identified a chromosome 16q segment shared by all affected individuals. When the program FASTLINK/LINKAGE was used and a completely penetrant autosomal recessive mode of inheritance was assumed, a maximum LOD score of 4.44 was observed for a recombination fraction of 0, with marker D16S3067. A five-marker haplotype (D16S3067, D16S752, D16S2624, D16S3025, and D16S3106) spanning 4.9 cM was shared by all patients. These results provide significant evidence of linkage for a candidate gene on chromosome 16q22.
Collapse
Affiliation(s)
- Christine Bétard
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Andrée Rasquin-Weber
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Carl Brewer
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Eric Drouin
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Suzanne Clark
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Andrei Verner
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Corinne Darmond-Zwaig
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Julie Fortin
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Jocelyne Mercier
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Pierre Chagnon
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - T. Mary Fujiwara
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Kenneth Morgan
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Andrea Richter
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Thomas J. Hudson
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Grant A. Mitchell
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| |
Collapse
|
12
|
Fanella S, Harris SB, Young TK, Hanley AJ, Zinman B, Connelly PW, Hegele RA. Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations. Clin Chem Lab Med 2000; 38:413-20. [PMID: 10952224 DOI: 10.1515/cclm.2000.060] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Serum paraoxonase circulates on a subfraction of high density lipoproteins and appears to use phospholipids on both low and high density lipoprotein particles as a physiological substrate. This functional relationship could explain the reported associations between common variation in the PON1 gene--at codons 55 and 192--and phenotypes related to atherosclerosis and lipoprotein metabolism. We evaluated associations between plasma lipoproteins and PON1 L/M55, PON1 Q/R192 and PON2 A/G148 polymorphisms in samples from two Canadian aboriginal populations, namely the Oji-Cree and the Inuit. In diabetic Oji-Cree, we found that carriers of PON1 M55 had a higher mean plasma triglyceride concentration than non-carriers. In non-diabetic Oji-Cree, we found that carriers of PON1 M55 had higher mean plasma concentrations of total and low density lipoporetein cholesterol and apo B than non-carriers. In Inuit, we found that carriers of PON1 M55 had higher mean plasma concentrations of total and low density lipoprotein cholesterol than non-carriers. The other polymorphic markers were not associated with variation in any plasma lipoprotein trait. Thus, the PON1 M55 allele appeared to be associated with deleterious changes in the plasma lipoprotein profile from two independent Canadian aboriginal samples. These results suggest that common variation in PON1 codon 55 is associated with variation of intermediate traits in plasma lipoprotein metabolism in aboriginal Canadians.
Collapse
Affiliation(s)
- S Fanella
- Robarts Research Institute, University of Western Ontario, London, Canada
| | | | | | | | | | | | | |
Collapse
|
13
|
Abstract
The paraoxonase gene family contains at least three members, including PON1, PON2 and PON3, which are located on chromosome 7q21.3-22.1. Until recently, there has been little insight into the role of the respective gene products in human physiology and pathology. However, emerging evidence from biochemical and genetic experiments is providing clues about the role(s) of the products of these genes. For example, the PON1 gene product is serum paraoxonase, which is expressed mainly in the liver and which hydrolyzes organophosphates. Serum paraoxonase circulates on a subfraction of high-density lipoproteins and appears to use phospholipids on both low and high-density lipoprotein particles as a physiological substrate. This functional relationship could explain the reported associations between common variation in the PON1 gene and phenotypes related to atherosclerosis and lipoprotein metabolism. In contrast, the PON2 mRNA is expressed ubiquitously, and to date there are no mechanistic experiments that yield insights into its physiological role. However, there have been reports of association between common variation in PON2 and some metabolic quantitative phenotypes, such as plasma lipoproteins, plasma glucose, birthweight and atherosclerosis. Such genetic associations could point to the possible physiological role(s) of PON2. At present, the role of the PON3 gene product is very poorly understood. Complementary lines of research should soon clarify whether there might be merit in clinical testing for genetic variation in the paraoxonase gene family or whether the gene products might be good candidates for therapeutic interventions.
Collapse
Affiliation(s)
- R A Hegele
- John P Robarts Research Institute, Department of Medicine, University of Western Ontario, London, Canada.
| |
Collapse
|